Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity

Br J Cancer. 2008 Jun 3;98(11):1781-3. doi: 10.1038/sj.bjc.6604392. Epub 2008 May 27.


We examined the association between non-steroidal anti-inflammatory drug (NSAID) use and ovarian cancer by potential effect modifiers, parity and oral contraceptive use, in a population-based case-control study conducted in Wisconsin and Massachusetts. Women reported prior use of NSAIDs and information on risk factors in a telephone interview. A total of 487 invasive ovarian cancer cases and 2653 control women aged 20-74 years were included in the analysis. After adjustment for age, state of residence and other covariates, ever use of NSAIDs was inversely associated with ovarian cancer in never users of oral contraceptives (odds ratio (OR)=0.58, 95% confidence interval (CI) 0.42-0.80) but not for ever users (OR=0.98, 95% CI 0.71-1.35) (P-interaction=0.03). A reduced risk with NSAID use was also noted in nulliparous women (OR=0.47, 95% CI 0.27-0.82) but not among parous women (OR=0.81, 95% CI 0.64-1.04) (P-interaction=0.05). These results suggest that use of NSAIDs were beneficial to women at greatest risk for ovarian cancer.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Case-Control Studies
  • Contraceptives, Oral / pharmacology*
  • Female
  • Humans
  • Inflammation / complications
  • Middle Aged
  • Ovarian Neoplasms / etiology
  • Ovarian Neoplasms / prevention & control*
  • Ovulation
  • Parity*
  • Pregnancy


  • Anti-Inflammatory Agents, Non-Steroidal
  • Contraceptives, Oral